CURE CLCN4 LTD
We are a registered charity aimed at providing support, raising awareness and funding medical research for effective treatments for CLCN4. CLCN4 is a rare genetic condition that causes intellectual disability and other problems such as epilepsy, behavioural disorders, movement disorders and microcephaly.
Financial health, per its FY2025 accounts
The accounts state that the charity held free reserves of £(8,657) at the end of the period, which is below the trustees' target of 5–6 months of operating expenditure. The trustees report that this deficit is expected to be replenished in early 2026 by a cash donation from a trustee, and they confirm there are no uncertainties regarding the charity's ability to continue as a going concern.
What the accounts disclose
“Donations (Note 3) include a £141,681 contribution made by P Trill, a director of the company.” — page 21
“At 31 December 2025, the charity held free reserves of £(8,657) (2024: £3,401). This is below the target range set by the Trustees.”
“Donations (Note 3) include a £141,681 contribution made by P Trill, a director of the company. At 31 December 2025, £18,046 (2024 - £18,046) was owed to P Trill in relation to expense payments made on behalf of the company.” — page 21
Trustees
- Peter James Alistair Trillchair
- Alexis Karim
- Dr Alan Wise
- Larry Louison
- Paul McGuinness
- Wang Sin Tan
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2025 | £185k | £197k |
| 31/12/2024 | £89k | £89k |
| 31/12/2023 | £78k | £119k |
| 31/12/2022 | £23k | £45k |
| 31/12/2021 | £108k | £33k |
Common questions
Is CURE CLCN4 LTD financially healthy?
Per its FY2025 accounts: The accounts state that the charity held free reserves of £(8,657) at the end of the period, which is below the trustees' target of 5–6 months of operating expenditure. The trustees report that this deficit is expected to be replenished in early 2026 by a cash donation from a trustee, and they confirm there are no uncertainties regarding the charity's ability to continue as a going concern. Its FY2025 accounts were independently examined.
Who funds CURE CLCN4 LTD?
Funders whose own accounts filings name CURE CLCN4 LTD as a grant recipient include UBS UK Donor-Advised Foundation, HIGHWAY ONE TRUST.
Known funders
| Funder | Year | Amount | Purpose (as stated by the funder) |
|---|---|---|---|
| UBS UK Donor-Advised Foundation | FY2021 | £98k | |
| HIGHWAY ONE TRUST | FY2024 | £7k |
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| DORIS FIELD CHARITABLE TRUST | 2 | £2k |
| THE REED FOUNDATION | 1 | — |
| MAKERS OF PLAYING CARDS CHARITY | 1 | — |
| THE EDWARD GOSTLING FOUNDATION | 1 | £250k |
| CHARITY OF RICHARD CLOUDESLEY | 1 | £132k |
| BERNARD LEWIS FAMILY CHARITABLE TRUST | 1 | £90k |
| The Greaves & Withey Foundation | 1 | £42k |
| YOUNG CAMDEN FOUNDATION | 1 | £32k |
Charities like this
- THE FOUR SEASONS TRUST LIMITED
- CLEFT
- THE CHRONIC GRANULOMATOUS DISORDER SOCIETY
- CURE INTERNATIONAL (UK)
- CENTRE 404
- Chilterns Neuro Centre Ltd
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| CURE CLCN4 LTD | £185k | — | 0 | below | — | no doubt |
| THE FOUR SEASONS TRUST LIMITED | £425k | — | — | unclear | — | no doubt |
| CLEFT | £325k | — | 0 | above | — | no doubt |
| THE CHRONIC GRANULOMATOUS DISORDER SOCIETY | £359k | — | 0 | within | 41.0% | no doubt |
| CURE INTERNATIONAL (UK) | £461k | — | 0 | below | — | no doubt |
| CENTRE 404 | £10.6m | — | 0 | unclear | — | no doubt |